Drug Shortages: Additional Information
| Drug Name | Company Information | Related Information |
|---|---|---|
| Lactated Ringer's Injection USP, 1000 mL (NDC 0264-7750-00) | B. Braun Medical Inc. 800-227-2862 | BBraun Customer Letter IV Solution Shortage |
| Metronidazole Injection USP 500 mg (5 mg/mL), 100 mL (NDC 0264-5535-32) | B. Braun Medical Inc. 800-227-2862 | BBraun Customer Letter IV Solution Shortage |
| 5% Dextrose Injection USP, 25 mL (NDC 0264-1510-36) | B. Braun Medical Inc. 800-227-2862 | BBraun Customer Letter IV Solution Shortage |
| 5% Dextrose Injection USP, 50 mL (NDC 0264-1510-31) | B. Braun Medical Inc. 800-227-2862 | BBraun Customer Letter IV Solution Shortage |
| 5% Dextrose Injection USP, 100 mL (NDC 0264-1510-32) | B. Braun Medical Inc. 800-227-2862 | BBraun Customer Letter IV Solution Shortage |
| 0.9% Sodium Chloride Injection USP, 25 mL (NDC 0264-1800-36) | B. Braun Medical Inc. 800-227-2862 | BBraun Customer Letter IV Solution Shortage |
| 0.9% Sodium Chloride Injection USP, 50 mL (NDC 0264-1800-36) | 0.9% Sodium Chloride Injection USP, 50 mL (NDC 0264-1800-36) B. Braun Medical Inc. 800-227-2862 | BBraun Customer Letter IV Solution Shortage |
| 0.9% Sodium Chloride Injection USP, 100 mL (NDC 0264-1800-32) | B. Braun Medical Inc. 800-227-2862 | BBraun Customer Letter IV Solution Shortage |
Potassium Acetate 40 meq/20mL (2 meq/mL) Injection
| Applicant: Exela Pharma Sciences, (888) 451-4321 | Product is available through direct orders. (888) 451-4321 The current carton and vial labels for Exela’s Potassium Acetate 40 meq/20 mL (2 meq/mL) Injection indicate the product contains an aluminum level of not more than 200 mcg/L. We have determined that the actual aluminum level in some instances may exceed 200 mcg/L in the product. See attached DHCP letter for information. |
| Sodium Phosphates Injection, USP 45 mM P/15 mL (3 mM P/mL); 60 mEq Na+ /15mL (4.0 mEq/mL) NDC 0409‐7391‐72 | Hospira, Inc. Company Contact Information: 844-646-4398 | Correction to osmolarity concentration on Sodium Phosphates Injections, USP labeling. Sodium Phosphates Notification Letter |
| Potassium Phosphates Injection, USP 45 mM P/15 mL (3 mM P/mL); 66 mEq K+ /15mL (4.4 mEq/mL) NDC 0409‐7295‐01 | Hospira, Inc. Company Contact Information: 844-646-4398 | Correction to osmolarity concentration on Potassium Phosphates Injections, USP labeling. Potassium Phosphates Notification Letter |
| Alkeran (Melphalan) 2 MG Tablets; Bottle of 50 (NDC 52609-0001-5) | Applicant: Apotex Inc, (416) 749-9300 |
|
| PRIALT® (ziconotide) Solution, Intrathecal Infusion 25 mcg/mL PRIALT in 20 mL vial (NDC# 18860-0723-10) | Jazz Pharmaceuticals, Inc. 1‐800‐520‐5568 | PRIALT® (ziconotide) Solution, Intrathecal Infusion is provided in the US in three presentations:
|
Sacrosidase Oral Solution, 8500 IU/mL, Updated 7/27/17 | QOL Medical, LLC 1-866-469-3773 | Limited Supply Available |
